Abbott pleads guilty, $1.5 billion fine sets new record - for now
Abbott Laboratories pleaded guilty to a criminal charge and agreed to pay $1.5 billion to federal and state governments for off-label promotion of the drug Depakote.
Abbott pleads guilty, $1.5 billion fine sets new record - for now
David Sell
The Justice Department, 49 states and the District of Columbia announced that Abbott Laboratories had pleaded guilty to criminal charges and agreed to pay $1.5 billion over allegations that it promoted the anti-seizure drug Depakote for uses unapproved by the U.S. Food and Drug Administration.
For the moment, that is the new record for the largest fine for bad behavior primarily focused on one drug.
The record is likely to surpassed if or when the Justice Department, several states and Johnson & Johnson settle on figures related to allegations of various bad behaviors related to Risperdal. (By the way, in Monday's SEC filing, J&J says it remains confident that the $1.1 billion fine it got in Arkansas will be overturned and it has not set aside money for it.)
Both drugs -- as are several in the high-fine category - are in the category of pharmaceuticals used to treat mental disorders or diseases or conditions.
James M. Cole, Deputy Attorney General, said in a statement that the “settlement shows further evidence of our deep commitment to public health and our determination to hold accountable those who commit fraud. We are resolute in stopping this type of activity and today’s settlement sends a strong message to other companies.”
Abbott's Laura J. Schumacher, executive vice president and general counsel, said in a statement, "We are pleased to resolve this matter and are confident we have the programs in place to satisfy the requirements of this settlement. The company takes its responsibility to patients and health care providers seriously and has established robust compliance programs to ensure its marketing programs meet the needs of health care providers and legal requirements."
A link to Justice Department site with numerous court documents is here.
A link to Abbott's statement is here.
You mean that Abbot's consumers will be paying the fine. Our "healthcare" system at it's sleaziest best. And dopes wonder why we pay 3X per capita more than the rest of the civilized world for much worse results. CiceroSpuriousDeodatus
Hope you don't get sick. There are options if you do....go to China and take some of those capsules they were making that are filled with baby flesh. SportsMess
OUCH. price increase in Pedialyte coming soon. bbewsirhc
Reg-Abbott labs off-label promotion of Depakote.
I took Depakote for 6 years was ineffective for my condition PTSD,the doctor kept telling me to take it.
The saga of the schizophrenia drugs is one of incredible profit.Eli Lilly made $65 BILLION on Zyprexa franchise. Described as *the most successful drug in the history of neuroscience*.There is a whole underclass block of our society,including children in foster care that are the market for these drugs,but have little voice of protest if harmed by them.
--Daniel Haszard DannyHaszard
Abbott's VP said "they're pleased to resolve this matter". The reason
that they're pleased is that they only have to pay a fine of $1.5 Billion instead of the anticipated fine of $2 Billion. farley
- Adolor
- Almac
- AmerisourceBergen
- AstraZeneca
- Auxilium
- Bayer
- Celgene
- Cephalon
- Endo
- GlaxoSmithKline
- Johnson & Johnson
- Kensey Nash
- Lannett
- Merck
- Pfizer
- Roche
- Sanofi-aventis
- Shire
- Stryker
- Synthes
- Teva
- ViroPharma
- West
- Centers for Disease Control and Prevention
- Centers for Medicare and Medicaid
- Clinical Trials
- Food and Drug Administration
- Office of Inspector General, Health and Human Services
- OIG Most-wanted list of fugitives
- Securities and Exchange Commission/Edgar filings
- U.S. Attorney's Office/Eastern Pennsylvania, health-care fraud
- U.S. Department of Health and Human Services
- BIO
- Jersey Association of Medical Equipment Services
- Pennsylvania Association of Medical Suppliers
- Pharmaceutical Research and Manufacturers of America
- Science Center
- American Health Lawyers Association
- Drug and Device Law
- Orange Book blog
- Taxpayers Against Fraud
- Bio Century
- Bio Space
- Cafe Pharma
- Financial Times
- In The Pipeline
- Monday Morning
- New York Times/Prescriptions
- Pharma Live
- Pharma Marketing
- Pharmalot
- The Placebo Effect
- Wall Street Journal/Health blog


